In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Oxonica completes its £7.1mm IPO

Executive Summary

Oxonica PLC (nanotechnology used in the healthcare and environmental sectors) has raised £7.1mm ($12.4mm) with the initial public offering of 8.66mm new ordinary shares (about 23.5% of the company's outstanding shares) priced at £0.96 each. Oxonica's shares will now trade on the AIM of the London Stock Exchange.
Deal Industry
  • Pharmaceuticals
  • Research, Analytical Equipment & Supplies
  • Biotechnology
    • Nanotechnology, Chips, etc.
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies